Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells.
Jin Soo ParkHyun Kuk KimEun Young KangRyeonJin ChoYeon-Mok OhPublished in: Tuberculosis and respiratory diseases (2018)
PioWJMSCs may produce greater lung regeneration, compared to non-augmented WJMSCs, in a mouse emphysema model.